Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma

SIMPLE SUMMARY: A majority of melanoma occurs in people over 65 years. BRAF and MEK inhibitors are standard of care for BRAF mutated metastatic melanoma. The aim of the study was to explore tolerability of targeted therapy in a cohort of patients extracted from a biobank. Patients treated by BRAF an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Becquart, Ondine, Oriano, Bastien, Dalle, Stéphane, Mortier, Laurent, Leccia, Marie Thérèse, Dutriaux, Caroline, Dalac, Sophie, Montaudié, Henri, De Quatrebarbes, Julie, Brunet-Possenti, Florence, Saiag, Philippe, Lesimple, Thierry, Beylot-Barry, Marie, Aubin, Francois, Stoebner, Pierre-Emmanuel, Arnault, Jean-Philippe, Dreno, Brigitte, Porcher, Raphael, Lebbe, Celeste, Guillot, Bernard
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8235702/
https://ncbi.nlm.nih.gov/pubmed/34207200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados